Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1
Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential...
Gespeichert in:
Veröffentlicht in: | Diabetes & vascular disease research 2008-09, Vol.5 (3), p.198-204 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 204 |
---|---|
container_issue | 3 |
container_start_page | 198 |
container_title | Diabetes & vascular disease research |
container_volume | 5 |
creator | Augstein, Petra Heinke, Peter Salzsieder, Eckhard Grimm, Rita Giebel, Jürgen Salzsieder, Christel Harrison, Leonard C |
description | Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1. NIT-1 cells were exposed to the interleukin-1 β/interferon-γ (IL-1 β/IFN-γ) cytokine combination to induce apoptosis in vitro. Low concentrations of cytokines resulted in ΔΨm impairment, and increasing concentrations had only a minor additional effect. Treatment with the inducible nitric oxide synthase (iNOS) inhibitor Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) prevented cytokine-mediated ΔΨm impairment, implying that cytokines affect ΔΨm via nitric oxide. The broad-spectrum caspase inhibitor Z-VAD(Ome)-FMK (ZVAD) revealed dichotomic actions. In the presence of ZVAD, cytokine-induced nitrite generation was increased but cell death and ΔΨm impairment were reduced. ΔΨm impairment was also reduced by inhibitors of caspases 1, 6 and 8. Induction of Fas by IL-1 β/IFN-γ coupled with activation by Super-FasL augmented cytokine-induced cell death. We observed a clear dominance of cytokine- over FasL-induced effects on ΔΨm.
Our findings show that IL-1 β/IFN-γ cytokines have a strong effect to impair ΔΨm and prime β-cells for apoptosis via the intrinsic pathway mediated by iNOS and caspases. Furthermore, at least in NIT-1 cells, the extrinsic FasL/Fas pathway has only a minor additive effect on cytokine-induced ΔΨm impairment. |
doi_str_mv | 10.3132/dvdr.2008.032 |
format | Article |
fullrecord | <record><control><sourceid>proquest_AFRWT</sourceid><recordid>TN_cdi_proquest_miscellaneous_69518475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.3132_dvdr.2008.032</sage_id><sourcerecordid>69518475</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2802-e41049f74a27863d71bd295013f76133730ed6b8b2ed881230829cdd236423bb3</originalsourceid><addsrcrecordid>eNp1kL9uFDEQhy1EREKgpEWuECD58L9de8soEBLpFJpQW17bSxzW9mLvRspD0PEQ1DzIPRNe7iSqVDMaff7N-APgFcEbRhj9YO9t3lCM5QYz-gScENFQJDvJn9aeiw6RlpNj8LyUO4ybVjTyGTgmUgjBO3YCfn5MwUcdjYNpgOZhTt99dAime5fhhS5b5KNdjLPQh0n7HFycV3K-dTD4OZnbFG32eoRz1rEEF_paHZzSXMl1_nb3a_c7vIM-_ns01V3Z6dkbuPuDjBtHONaN8PrqBpEX4GjQY3EvD_UUfL34dHN-ibZfPl-dn22RoRJT5DjBvBsE11TIlllBeku7BhM2iJYwJhh2tu1lT52VklCGJe2MtZS1nLK-Z6fgzT53yunH4sqsgi_rLfX0tBTVdg2RXDQVRHvQ5FRKdoOasg86PyiC1epfrf7V6l9V_5V_fQhe-uDsf_ogvALv90DR35y6S0uO9aOPpP0FTQyRDQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69518475</pqid></control><display><type>article</type><title>Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1</title><source>Sage Journals GOLD Open Access 2024</source><creator>Augstein, Petra ; Heinke, Peter ; Salzsieder, Eckhard ; Grimm, Rita ; Giebel, Jürgen ; Salzsieder, Christel ; Harrison, Leonard C</creator><creatorcontrib>Augstein, Petra ; Heinke, Peter ; Salzsieder, Eckhard ; Grimm, Rita ; Giebel, Jürgen ; Salzsieder, Christel ; Harrison, Leonard C</creatorcontrib><description>Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1. NIT-1 cells were exposed to the interleukin-1 β/interferon-γ (IL-1 β/IFN-γ) cytokine combination to induce apoptosis in vitro. Low concentrations of cytokines resulted in ΔΨm impairment, and increasing concentrations had only a minor additional effect. Treatment with the inducible nitric oxide synthase (iNOS) inhibitor Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) prevented cytokine-mediated ΔΨm impairment, implying that cytokines affect ΔΨm via nitric oxide. The broad-spectrum caspase inhibitor Z-VAD(Ome)-FMK (ZVAD) revealed dichotomic actions. In the presence of ZVAD, cytokine-induced nitrite generation was increased but cell death and ΔΨm impairment were reduced. ΔΨm impairment was also reduced by inhibitors of caspases 1, 6 and 8. Induction of Fas by IL-1 β/IFN-γ coupled with activation by Super-FasL augmented cytokine-induced cell death. We observed a clear dominance of cytokine- over FasL-induced effects on ΔΨm.
Our findings show that IL-1 β/IFN-γ cytokines have a strong effect to impair ΔΨm and prime β-cells for apoptosis via the intrinsic pathway mediated by iNOS and caspases. Furthermore, at least in NIT-1 cells, the extrinsic FasL/Fas pathway has only a minor additive effect on cytokine-induced ΔΨm impairment.</description><identifier>ISSN: 1479-1641</identifier><identifier>EISSN: 1752-8984</identifier><identifier>DOI: 10.3132/dvdr.2008.032</identifier><identifier>PMID: 18777493</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Amino Acid Chloromethyl Ketones - pharmacology ; Animals ; Apoptosis ; Caspase Inhibitors ; Caspases - metabolism ; Cell Line ; Enzyme Inhibitors - pharmacology ; Fas Ligand Protein - metabolism ; Insulin-Secreting Cells - drug effects ; Insulin-Secreting Cells - enzymology ; Insulin-Secreting Cells - immunology ; Insulin-Secreting Cells - pathology ; Interferon-gamma - metabolism ; Interleukin-1beta - metabolism ; Membrane Potential, Mitochondrial ; Mice ; Mitochondria - drug effects ; Mitochondria - enzymology ; Mitochondria - immunology ; Mitochondria - pathology ; NG-Nitroarginine Methyl Ester - pharmacology ; Nitric Oxide - metabolism ; Nitric Oxide Synthase Type II - antagonists & inhibitors ; Nitric Oxide Synthase Type II - metabolism ; Nitrites - metabolism ; Recombinant Proteins - metabolism ; Time Factors</subject><ispartof>Diabetes & vascular disease research, 2008-09, Vol.5 (3), p.198-204</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2802-e41049f74a27863d71bd295013f76133730ed6b8b2ed881230829cdd236423bb3</citedby><cites>FETCH-LOGICAL-c2802-e41049f74a27863d71bd295013f76133730ed6b8b2ed881230829cdd236423bb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.3132/dvdr.2008.032$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.3132/dvdr.2008.032$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21965,27852,27923,27924,44944,45332</link.rule.ids><linktorsrc>$$Uhttps://journals.sagepub.com/doi/full/10.3132/dvdr.2008.032?utm_source=summon&utm_medium=discovery-provider$$EView_record_in_SAGE_Publications$$FView_record_in_$$GSAGE_Publications</linktorsrc><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18777493$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Augstein, Petra</creatorcontrib><creatorcontrib>Heinke, Peter</creatorcontrib><creatorcontrib>Salzsieder, Eckhard</creatorcontrib><creatorcontrib>Grimm, Rita</creatorcontrib><creatorcontrib>Giebel, Jürgen</creatorcontrib><creatorcontrib>Salzsieder, Christel</creatorcontrib><creatorcontrib>Harrison, Leonard C</creatorcontrib><title>Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1</title><title>Diabetes & vascular disease research</title><addtitle>Diab Vasc Dis Res</addtitle><description>Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1. NIT-1 cells were exposed to the interleukin-1 β/interferon-γ (IL-1 β/IFN-γ) cytokine combination to induce apoptosis in vitro. Low concentrations of cytokines resulted in ΔΨm impairment, and increasing concentrations had only a minor additional effect. Treatment with the inducible nitric oxide synthase (iNOS) inhibitor Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) prevented cytokine-mediated ΔΨm impairment, implying that cytokines affect ΔΨm via nitric oxide. The broad-spectrum caspase inhibitor Z-VAD(Ome)-FMK (ZVAD) revealed dichotomic actions. In the presence of ZVAD, cytokine-induced nitrite generation was increased but cell death and ΔΨm impairment were reduced. ΔΨm impairment was also reduced by inhibitors of caspases 1, 6 and 8. Induction of Fas by IL-1 β/IFN-γ coupled with activation by Super-FasL augmented cytokine-induced cell death. We observed a clear dominance of cytokine- over FasL-induced effects on ΔΨm.
Our findings show that IL-1 β/IFN-γ cytokines have a strong effect to impair ΔΨm and prime β-cells for apoptosis via the intrinsic pathway mediated by iNOS and caspases. Furthermore, at least in NIT-1 cells, the extrinsic FasL/Fas pathway has only a minor additive effect on cytokine-induced ΔΨm impairment.</description><subject>Amino Acid Chloromethyl Ketones - pharmacology</subject><subject>Animals</subject><subject>Apoptosis</subject><subject>Caspase Inhibitors</subject><subject>Caspases - metabolism</subject><subject>Cell Line</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Fas Ligand Protein - metabolism</subject><subject>Insulin-Secreting Cells - drug effects</subject><subject>Insulin-Secreting Cells - enzymology</subject><subject>Insulin-Secreting Cells - immunology</subject><subject>Insulin-Secreting Cells - pathology</subject><subject>Interferon-gamma - metabolism</subject><subject>Interleukin-1beta - metabolism</subject><subject>Membrane Potential, Mitochondrial</subject><subject>Mice</subject><subject>Mitochondria - drug effects</subject><subject>Mitochondria - enzymology</subject><subject>Mitochondria - immunology</subject><subject>Mitochondria - pathology</subject><subject>NG-Nitroarginine Methyl Ester - pharmacology</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Synthase Type II - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase Type II - metabolism</subject><subject>Nitrites - metabolism</subject><subject>Recombinant Proteins - metabolism</subject><subject>Time Factors</subject><issn>1479-1641</issn><issn>1752-8984</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kL9uFDEQhy1EREKgpEWuECD58L9de8soEBLpFJpQW17bSxzW9mLvRspD0PEQ1DzIPRNe7iSqVDMaff7N-APgFcEbRhj9YO9t3lCM5QYz-gScENFQJDvJn9aeiw6RlpNj8LyUO4ybVjTyGTgmUgjBO3YCfn5MwUcdjYNpgOZhTt99dAime5fhhS5b5KNdjLPQh0n7HFycV3K-dTD4OZnbFG32eoRz1rEEF_paHZzSXMl1_nb3a_c7vIM-_ns01V3Z6dkbuPuDjBtHONaN8PrqBpEX4GjQY3EvD_UUfL34dHN-ibZfPl-dn22RoRJT5DjBvBsE11TIlllBeku7BhM2iJYwJhh2tu1lT52VklCGJe2MtZS1nLK-Z6fgzT53yunH4sqsgi_rLfX0tBTVdg2RXDQVRHvQ5FRKdoOasg86PyiC1epfrf7V6l9V_5V_fQhe-uDsf_ogvALv90DR35y6S0uO9aOPpP0FTQyRDQ</recordid><startdate>200809</startdate><enddate>200809</enddate><creator>Augstein, Petra</creator><creator>Heinke, Peter</creator><creator>Salzsieder, Eckhard</creator><creator>Grimm, Rita</creator><creator>Giebel, Jürgen</creator><creator>Salzsieder, Christel</creator><creator>Harrison, Leonard C</creator><general>SAGE Publications</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200809</creationdate><title>Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1</title><author>Augstein, Petra ; Heinke, Peter ; Salzsieder, Eckhard ; Grimm, Rita ; Giebel, Jürgen ; Salzsieder, Christel ; Harrison, Leonard C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2802-e41049f74a27863d71bd295013f76133730ed6b8b2ed881230829cdd236423bb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Amino Acid Chloromethyl Ketones - pharmacology</topic><topic>Animals</topic><topic>Apoptosis</topic><topic>Caspase Inhibitors</topic><topic>Caspases - metabolism</topic><topic>Cell Line</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Fas Ligand Protein - metabolism</topic><topic>Insulin-Secreting Cells - drug effects</topic><topic>Insulin-Secreting Cells - enzymology</topic><topic>Insulin-Secreting Cells - immunology</topic><topic>Insulin-Secreting Cells - pathology</topic><topic>Interferon-gamma - metabolism</topic><topic>Interleukin-1beta - metabolism</topic><topic>Membrane Potential, Mitochondrial</topic><topic>Mice</topic><topic>Mitochondria - drug effects</topic><topic>Mitochondria - enzymology</topic><topic>Mitochondria - immunology</topic><topic>Mitochondria - pathology</topic><topic>NG-Nitroarginine Methyl Ester - pharmacology</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Synthase Type II - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase Type II - metabolism</topic><topic>Nitrites - metabolism</topic><topic>Recombinant Proteins - metabolism</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Augstein, Petra</creatorcontrib><creatorcontrib>Heinke, Peter</creatorcontrib><creatorcontrib>Salzsieder, Eckhard</creatorcontrib><creatorcontrib>Grimm, Rita</creatorcontrib><creatorcontrib>Giebel, Jürgen</creatorcontrib><creatorcontrib>Salzsieder, Christel</creatorcontrib><creatorcontrib>Harrison, Leonard C</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Diabetes & vascular disease research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Augstein, Petra</au><au>Heinke, Peter</au><au>Salzsieder, Eckhard</au><au>Grimm, Rita</au><au>Giebel, Jürgen</au><au>Salzsieder, Christel</au><au>Harrison, Leonard C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1</atitle><jtitle>Diabetes & vascular disease research</jtitle><addtitle>Diab Vasc Dis Res</addtitle><date>2008-09</date><risdate>2008</risdate><volume>5</volume><issue>3</issue><spage>198</spage><epage>204</epage><pages>198-204</pages><issn>1479-1641</issn><eissn>1752-8984</eissn><abstract>Mitochondria of pancreatic β-cells are potential targets of intrinsic and extrinsic apoptotic pathways in the autoimmune pathogenesis of type 1 diabetes. We aimed to investigate whether cytokine- and FasLigand (FasL)-induced apoptosis is associated with impaired mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1. NIT-1 cells were exposed to the interleukin-1 β/interferon-γ (IL-1 β/IFN-γ) cytokine combination to induce apoptosis in vitro. Low concentrations of cytokines resulted in ΔΨm impairment, and increasing concentrations had only a minor additional effect. Treatment with the inducible nitric oxide synthase (iNOS) inhibitor Nω-nitro-L-arginine methyl ester hydrochloride (L-NAME) prevented cytokine-mediated ΔΨm impairment, implying that cytokines affect ΔΨm via nitric oxide. The broad-spectrum caspase inhibitor Z-VAD(Ome)-FMK (ZVAD) revealed dichotomic actions. In the presence of ZVAD, cytokine-induced nitrite generation was increased but cell death and ΔΨm impairment were reduced. ΔΨm impairment was also reduced by inhibitors of caspases 1, 6 and 8. Induction of Fas by IL-1 β/IFN-γ coupled with activation by Super-FasL augmented cytokine-induced cell death. We observed a clear dominance of cytokine- over FasL-induced effects on ΔΨm.
Our findings show that IL-1 β/IFN-γ cytokines have a strong effect to impair ΔΨm and prime β-cells for apoptosis via the intrinsic pathway mediated by iNOS and caspases. Furthermore, at least in NIT-1 cells, the extrinsic FasL/Fas pathway has only a minor additive effect on cytokine-induced ΔΨm impairment.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><pmid>18777493</pmid><doi>10.3132/dvdr.2008.032</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | ISSN: 1479-1641 |
ispartof | Diabetes & vascular disease research, 2008-09, Vol.5 (3), p.198-204 |
issn | 1479-1641 1752-8984 |
language | eng |
recordid | cdi_proquest_miscellaneous_69518475 |
source | Sage Journals GOLD Open Access 2024 |
subjects | Amino Acid Chloromethyl Ketones - pharmacology Animals Apoptosis Caspase Inhibitors Caspases - metabolism Cell Line Enzyme Inhibitors - pharmacology Fas Ligand Protein - metabolism Insulin-Secreting Cells - drug effects Insulin-Secreting Cells - enzymology Insulin-Secreting Cells - immunology Insulin-Secreting Cells - pathology Interferon-gamma - metabolism Interleukin-1beta - metabolism Membrane Potential, Mitochondrial Mice Mitochondria - drug effects Mitochondria - enzymology Mitochondria - immunology Mitochondria - pathology NG-Nitroarginine Methyl Ester - pharmacology Nitric Oxide - metabolism Nitric Oxide Synthase Type II - antagonists & inhibitors Nitric Oxide Synthase Type II - metabolism Nitrites - metabolism Recombinant Proteins - metabolism Time Factors |
title | Dominance of cytokine- over FasL-induced impairment of the mitochondrial transmembrane potential (ΔΨm) in the pancreatic β-cell line NIT-1 |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T04%3A36%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_AFRWT&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Dominance%20of%20cytokine-%20over%20FasL-induced%20impairment%20of%20the%20mitochondrial%20transmembrane%20potential%20(%CE%94%CE%A8m)%20in%20the%20pancreatic%20%CE%B2-cell%20line%20NIT-1&rft.jtitle=Diabetes%20&%20vascular%20disease%20research&rft.au=Augstein,%20Petra&rft.date=2008-09&rft.volume=5&rft.issue=3&rft.spage=198&rft.epage=204&rft.pages=198-204&rft.issn=1479-1641&rft.eissn=1752-8984&rft_id=info:doi/10.3132/dvdr.2008.032&rft_dat=%3Cproquest_AFRWT%3E69518475%3C/proquest_AFRWT%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69518475&rft_id=info:pmid/18777493&rft_sage_id=10.3132_dvdr.2008.032&rfr_iscdi=true |